The chemical class termed nucleobindin 2 activators encompasses a diverse range of compounds that, through various mechanisms, can modulate the activity of nucleobindin 2, a protein involved in calcium signaling and cellular stress responses. These compounds do not interact with nucleobindin 2 directly. Instead, their modes of action are primarily through the manipulation of intracellular calcium levels or the modulation of signaling pathways that indirectly influence nucleobindin 2 activity. For example, calcium ionophores like A23187 and X-537A operate by altering the calcium ion concentration within cells, a critical regulator of nucleobindin 2 due to its calcium-binding domains. Similarly, compounds such as Forskolin and cyclic AMP work by elevating cAMP levels, thereby activating protein kinase A (PKA) and influencing cellular processes that can modulate nucleobindin 2's function.
Furthermore, the involvement of these chemicals in the regulation of nucleobindin 2 underscores the protein's integral role in mediating cellular responses to changes in the internal and external environment. Through the manipulation of calcium dynamics, either by increasing calcium release with thapsigargin and ryanodine or by modulating calcium availability with chelators like BAPTA-AM and EGTA, these activators highlight the importance of calcium as a universal signaling molecule. Additionally, the action of caffeine and nifedipine points to the complexity of cellular signaling networks, where adenosine receptor antagonism and calcium channel blockade can indirectly influence nucleobindin 2 activity. Collectively, these compounds illustrate the interconnected nature of cellular signaling pathways and the multifaceted mechanisms through which nucleobindin 2 activity can be regulated, emphasizing the protein's role in maintaining cellular homeostasis and responding to physiological stresses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium levels, indirectly enhancing nucleobindin 2 activation due to its calcium-binding properties. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Elevates cAMP levels, promoting PKA activity which can modulate nucleobindin 2 through phosphorylation-dependent mechanisms. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and indirectly influencing nucleobindin 2 activity via PKA-dependent pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SARCO/ER Calcium ATPase, leading to increased cytosolic calcium and potentially enhancing nucleobindin 2 activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Blocks calcium channels, altering calcium homeostasis and indirectly impacting nucleobindin 2 activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Antagonizes adenosine receptors and releases intracellular calcium, indirectly influencing nucleobindin 2 activation. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Inhibits SERCA pumps, leading to increased intracellular calcium and indirectly enhancing nucleobindin 2 activity. | ||||||